• 1. Engineering the geometric and electronic structure of Ru via Ru–TiO2 interaction for enhanced selective hydrogenation
  Qiang Zhou,Zijiang Zhao,Zihao Yao,Zhongzhe Wei,Songtao Huang,Fangjun Shao,Aiyuan Li,Jianguo Wang Catal. Sci. Technol. 2022 12 1005
• 2. Tuning chemical compositions of bimetallic AuPd catalysts for selective catalytic hydrogenation of halogenated quinolines
  Sai Zhang,Zhaoming Xia,Ting Ni,Huan Zhang,Chao Wu,Yongquan Qu J. Mater. Chem. A 2017 5 3260
• 3. Inhibition of (dppf)nickel-catalysed Suzuki–Miyaura cross-coupling reactions by α-halo-N-heterocycles
  Alasdair K. Cooper,Megan E. Greaves,William Donohoe,Paul M. Burton,Thomas O. Ronson,Alan R. Kennedy,David J. Nelson Chem. Sci. 2021 12 14074
• 4. Cyclisation reactions of some pyridazinylimidoylketenes
  Alexander P. Gaywood,Lawrence Hill,S. Haider Imam,Hamish McNab,Gabor Neumajer,William J. O’Neill,Péter Mátyus New J. Chem. 2010 34 236
• 5. Electrochemical reactions. Part XV. Factors which determine the rate of carbon–halogen bond fragmentation in radical anions illustrated by some halogenated derivatives of quinoline, quinoxaline, and phenazine
  Khaled Alwair,James Grimshaw J. Chem. Soc. Perkin Trans. 2 1973 1811

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Introduction to 6-Chloroquinoline (CAS No. 612-57-7)

6-Chloroquinoline, with the chemical formula C₉H₅ClN₂, is a heterocyclic organic compound belonging to the quinoline family. This compound, identified by its CAS number 612-57-7, has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its versatile structural framework and potential biological activities. Quinoline derivatives, including 6-Chloroquinoline, have a long history of use in the development of drugs targeting various diseases, particularly those involving parasitic infections and certain types of cancer.

The structural integrity of 6-Chloroquinoline is characterized by a fused benzene and pyridine ring system, with a chlorine atom substituent at the 6-position. This substitution pattern imparts unique electronic and steric properties to the molecule, making it a valuable scaffold for further chemical modifications. The presence of the chlorine atom enhances the electrophilicity of the quinoline core, facilitating reactions such as nucleophilic aromatic substitution and cross-coupling, which are pivotal in drug synthesis.

In recent years, 6-Chloroquinoline has been extensively studied for its pharmacological properties. One of the most notable areas of research involves its potential as an antimalarial agent. Traditional antimalarial drugs like chloroquine have faced challenges due to the emergence of drug-resistant strains of *Plasmodium*. 6-Chloroquinoline, with its structural similarity to chloroquine, has been explored as a possible alternative or adjuvant therapy. Preliminary studies have suggested that derivatives of 6-Chloroquinoline may exhibit enhanced efficacy against drug-resistant malaria strains by inhibiting heme polymerization within the parasite's digestive vacuole.

Beyond antimalarial applications, 6-Chloroquinoline has shown promise in oncology research. The quinoline scaffold is known to interact with DNA and RNA, making it a candidate for developing chemotherapeutic agents. Researchers have investigated 6-Chloroquinoline derivatives for their ability to inhibit topoisomerases and other enzymes involved in DNA replication and transcription. Notably, certain modifications to the 6-Chloroquinoline core have demonstrated selective toxicity toward cancer cells while sparing healthy tissues, suggesting its potential as a lead compound for novel anticancer therapies.

The synthesis of 6-Chloroquinoline (CAS No. 612-57-7) typically involves chlorination reactions on quinoline or related precursors. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, have been employed to introduce functional groups at specific positions on the quinoline ring. These synthetic strategies allow for the generation of a diverse library of derivatives, enabling researchers to fine-tune the biological activity of the compound based on their specific therapeutic goals.

In addition to its pharmaceutical applications, 6-Chloroquinoline has found utility in materials science and chemical biology. Its ability to form coordination complexes with metal ions has been exploited in designing sensors and catalysts. For instance, complexes formed between 6-Chloroquinoline and transition metals like copper and zinc have been shown to exhibit luminescent properties, making them useful in bioimaging applications. Furthermore, these complexes can serve as catalysts in organic transformations, highlighting the compound's versatility beyond traditional medicinal chemistry.

The pharmacokinetic profile of 6-Chloroquinoline is another area of active investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for optimizing its therapeutic efficacy and minimizing potential side effects. Preclinical studies have begun to unravel the metabolic pathways involved in the biotransformation of 6-Chloroquinoline, providing insights into how structural modifications can influence its pharmacokinetics. These findings are essential for designing next-generation quinoline-based drugs with improved bioavailability and reduced toxicity.

Recent advancements in computational chemistry have further accelerated the discovery process for 6-Chloroquinoline derivatives. Molecular modeling techniques allow researchers to predict binding affinities and interactions between potential drug candidates and biological targets with high accuracy. By leveraging these computational tools, scientists can rapidly screen large libraries of quinoline derivatives virtualized before conducting expensive wet-lab experiments. This approach has significantly reduced the time required to identify promising lead compounds for further development.

The environmental impact of synthesizing and using 6-Chloroquinoline (CAS No. 612-57-7) is also a consideration in modern drug discovery efforts. Green chemistry principles are being applied to develop more sustainable synthetic routes that minimize waste and hazardous byproducts. For example, catalytic methods that employ recyclable catalysts or solvent-free reactions are being explored to reduce the ecological footprint associated with quinoline production.

In conclusion, 6-Chloroquinoline represents a fascinating compound with broad applications across pharmaceuticals, materials science, and chemical biology. Its unique structural features make it a versatile scaffold for developing drugs targeting diverse diseases, while its coordination chemistry opens new avenues in material design. As research continues to uncover new therapeutic potentials and sustainable synthetic methods, 6-choroquinolone (CAS No.: 5421) is poised to remain at forefront innovation in chemical biology.

• 4203-18-3(4,6-Dichloroquinoline)
• 1019-14-3(Acridine, 2,9-dichloro-)
• 86-98-6(4,7-Dichloroquinoline)
• 612-61-3(7-Chloroquinoline)
• 62383-19-1(Acridine, 2,6,9-trichloro-)
• 59304-30-2(Acridine, 3-chloro-)
• 1207-96-1(Acridine, 2-chloro-)
• 1207-69-8(9-Chloroacridine)
• 611-35-8(4-Chloroquinoline)
• 635-27-8(5-Chloroquinoline)